Established in 1987, the EuroQol Group first met to test the feasibility of jointly developing a standardized non disease specific instrument for describing and valuing health-related quality of life: EQ-5D.
Latest news
EuroQol extends free use of EQ-5D for non-commercial users
The Board of the EuroQol Research Foundation regularly reviews the EQ-5D user license policy. Recently,…
NICE commissions expert advice on EQ-5D-5L valuation set for England
Working in partnership with the Department of Health and Social Care, NICE has commissioned four…
EuroQol introduces the Interviewer Administered versions
The 3L and 5L Interviewer Administered versions (IA) were developed as amalgamated single versions to…
The Call for Abstracts for the 36th EQ Plenary Meeting is closed!
We kindly inform you that the Call for Abstracts for the 36th EuroQol Plenary Meeting…
Meetings
EuroQol extends free use of EQ-5D for non-commercial users
The Board of the EuroQol Research Foundation regularly reviews the EQ-5D user license policy. Recently,…
NICE commissions expert advice on EQ-5D-5L valuation set for England
Working in partnership with the Department of Health and Social Care, NICE has commissioned four…
EuroQol introduces the Interviewer Administered versions
The 3L and 5L Interviewer Administered versions (IA) were developed as amalgamated single versions to…
The Call for Abstracts for the 36th EQ Plenary Meeting is closed!
We kindly inform you that the Call for Abstracts for the 36th EuroQol Plenary Meeting…